The Therapeutic genome editing research group, directed by Dr. Mario Amendola, at the Genethon Institute in Evry, France, are seeking a highly motivated and talented postdoc to join their group working on the use of CRISPR and viral vectors to develop novel gene therapy technologies and approaches.
top of page
bottom of page
Comments